Evidence map›Paper›PMID 23958780›Full record

ArticleActa biomaterialia2013

Adaptable poly(ethylene glycol) microspheres capable of mixed-mode degradation.

M Parlato, A Johnson, G A Hudalla, W L Murphy

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microfluidic Chip Device forLangmuir : the ACS journal of surfaces and colloids · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M ParlatoDepartment of Biomedical Engineering, University of Wisconsin Madison, Wisconsin Institutes for Medical Research, 1111 Highland Ave., Madison, WI 53705, USA.
A Johnson
G A Hudalla
W L Murphy
University of Wisconsin–Madison · USWisconsin Institutes for Discovery · US

Funding

Biomaterials for local regulation of growth factor signalingR01HL093282 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MURPHY, WILLIAM L. · 2009 to 2018
$3.3M
Microsphere-mediated differentiation of embryonic stem cellsR01GM088291 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI MCDEVITT, TODD C · 2009 to 2013
$1.7M
Modulation of the Immune System to Improve Ligament/Ligament Graft HealingR01AR059916 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI MURPHY, WILLIAM L., VANDERBY, RAY · 2010 to 2014
$1.4M
NHLBI NIH HHS R01 HL093282NHLBI NIH HHS R01HL093282NIAMS NIH HHS R01AR059916NIGMS NIH HHS R01 GM088291
6 · The paper itself

Abstract

A simple, degradable poly(ethylene glycol) (PEG) microsphere system formed from a water-in-water emulsion process is presented. Microsphere network degradation and erosion were controlled by adjusting the number of hydrolytically labile sites, by varying the PEG molecular weight, and by adjusting the emulsion conditions. Microsphere size was also controllable by adjusting the polymer formulation. Furthermore, it is demonstrated that alternative degradation and erosion mechanisms, such as proteolytic degradation, can be incorporated into PEG microspheres, resulting in mixed-mode degradation. Owing to the adaptability of this approach, it may serve as an attractive option for emerging tissue engineering, drug delivery and gene delivery applications.

Indexed as

MicrospheresCollagenasesDithiothreitolEmulsionsMolecular WeightPeptidesPolyethylene GlycolsProteolysisCollagenasesDithiothreitolEmulsionsPeptidespoly(ethylene glycol)diacrylatePolyethylene GlycolsHydrogelsHydrolytic degradationMicrospheresPoly(ethylene glycol)Proteolytic degradation

Identifiers

PMID23958780
PMCPMC3907088
OpenAlexW2062902665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.